E2F1 and cancer: Based on clinical data from TCGA, we recently demonstrated that increased levels of E2F1, STAT3, and IL6, impacting cancer stemness and progression, correlate with CD4+ T helper type 2 (Th2) infiltration, while blocking Th1 in primary and metastatic melanoma.